Although mechanical ventilation (MV) is a life-saving intervention for patients with acute respiratory distress syndrome (ARDS), it can aggravate or cause lung injury, known as ventilator-induced lung injury (VILI). The biophysical characteristics of heterogeneously injured ARDS lungs increase the parenchymal stress associated with breathing, which is further aggravated by MV. Cells, in particular those lining the capillaries, airways and alveoli, transform this strain into chemical signals (mechanotransduction). The interaction of reparative and injurious mechanotransductive pathways leads to VILI. Several attempts have been made to identify clinical surrogate measures of lung stress/ strain (e.g., density changes in chest computed tomography, lower and upper inflection points of the pressure-volume curve, plateau pressure and inflammatory cytokine levels) that could be used to titrate MV. However, uncertainty about the topographical distribution of stress relative to that of the susceptibility of the cells and tissues to injury makes the existence of a single 'global' stress/strain injury threshold doubtful.
Keywordsacute lung injury; acute respiratory distress syndrome; esophageal pressure; lung strain; lung stress; mechanical ventilation; mechanotransduction; plateau pressure; ventilator-induced lung injury Acute respiratory distress syndrome (ARDS), as defined by the American-European Consensus Conference Committee, is a syndrome of inflammation and increased permeability associated with acute onset of hypoxemia (partial arterial oxygen pressure/fractional inspired oxygen [PaO 2 /FiO 2 ] ≤200 mmHg) accompanied by bilateral infiltrates on chest radiograph that cannot be explained by, but may coexist with, left atrial or pulmonary capillary hypertension (pulmonary artery occlusion pressure ≤18 mmHg) [1]. The term acute lung injury (ALI) implies a milder degree of hypoxemia (PaO 2 /FiO 2 ≤300 mmHg) [1]. It was first described by Ashbaugh et al. in 1967 in 12 patients, seven (58%) of whom died [2]. Mechanical ventilation (MV) is an integral part of ARDS therapy, but like all treatments, inappropriate application can lead to side effects, namely ventilator-induced lung injury (VILI). To date, limiting VILI through lower tidal volumes is the only intervention proven to reduce mortality in ARDS [3]. Patients randomized to a lower tidal volume (6 ml/kg) ventilation strategy had a 22% relative reduction in mortality compared with patients receiving 12 ml/kg [3]. Although mortality in patients with ALI/ ARDS in large randomized controlled trials in the last decade